TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Zuiko Corporation ( (JP:6279) ).
Zuiko Corporation has established a new subsidiary in Shanghai through its consolidated subsidiary, Zuiko (Shanghai) Corporation, to enhance its presence in the Chinese medical supplies market. This strategic move aligns with the company’s Fourth Medium-Term Business Plan, aiming to expand its business portfolio by developing sales channels for its wound dressing products in China, a market larger than Japan’s. The financial impact for the fiscal year ending February 2026 is expected to be minimal.
The most recent analyst rating on (JP:6279) stock is a Hold with a Yen1018.00 price target. To see the full list of analyst forecasts on Zuiko Corporation stock, see the JP:6279 Stock Forecast page.
More about Zuiko Corporation
Zuiko Corporation operates in the medical supplies industry, primarily focusing on the production and sale of medical devices such as wound dressings. The company’s market focus includes medical institutions, pharmacies, and general consumers in Japan, with a strategic expansion into the Chinese market.
Average Trading Volume: 56,516
Technical Sentiment Signal: Hold
Current Market Cap: Yen26.34B
See more data about 6279 stock on TipRanks’ Stock Analysis page.